Leukemia: Replaces damaged bone marrow in patients with acute or chronic leukemia, enabling the body to produce healthy blood cells.

In lymphoma, white blood cells called lymphocytes—which are essential for fighting infections—begin to grow uncontrollably. These cancerous lymphocytes accumulate in lymph nodes and other tissues, forming tumors that can spread to other parts of the body.

Multiple myeloma is a type of blood cancer that originates in plasma cells, a type of white blood cell found in bone marrow. Plasma cells are crucial to the immune system, as they produce antibodies that help the body fight infections. In multiple myeloma, these plasma cells become cancerous and multiply uncontrollably, crowding out normal, healthy cells in the bone marrow and leading to a range of health complications.

Potential Cure: Offers a potential cure for diseases like leukemia, lymphoma, multiple myeloma, and severe blood disorders.

Restores Healthy Blood Cell Production: Replaces damaged marrow, allowing for the production of red and white blood cells and platelets.

Boosts Immune Function: Helps patients with compromised immune systems build a new immune defense, reducing infections and complications.

Reduces Disease Symptoms: Alleviates symptoms like anemia, bleeding, fatigue, and frequent infections, improving overall health.

Extends Life Expectancy: Increases survival rates for patients with life-threatening blood cancers or bone marrow failure syndromes.

Lessens Dependency on Transfusions: Reduces or eliminates the need for regular blood transfusions in conditions like sickle cell disease and thalassemia.

• Initial Consultation and Evaluation
  
  Comprehensive Assessment: The patient undergoes a thorough medical evaluation, including blood tests, imaging (like CT or PET scans), and a bone marrow biopsy, to determine the severity of the disease and suitability for a transplant.
   

• Preparation (Conditioning Therapy) 
  
  Chemotherapy and/or Radiation: The patient receives high-dose chemotherapy, sometimes combined with radiation therapy, to:
  Destroy diseased cells in the bone marrow.
  Suppress the immune system to prevent rejection of donor cells (for allogeneic transplants).
  Side Effects Management: Conditioning can cause side effects, such as nausea, fatigue, and lowered immunity. The healthcare team provides supportive care to manage these.

• Stem Cell Collection (Harvesting)
  
  For Autologous Transplants: The patient’s stem cells are collected, usually from peripheral blood, after a process of mobilizing stem cells from the bone marrow into the bloodstream.
  For Allogeneic Transplants: The donor’s stem cells are collected either from peripheral blood (using apheresis) or directly from the bone marrow under anesthesia.

• Transplantation (Stem Cell Infusion)
  
  Stem Cell Infusion: The harvested stem cells are infused into the patient’s bloodstream through a central line IV, similar to a blood transfusion. 
  Waiting for Engraftment: After infusion, the stem cells travel to the bone marrow, where they begin producing new blood cells.

• Stem Cell Mobilization and Apheresis
  
  Stem Cell Mobilization Drugs: Medications like granulocyte-colony stimulating factors (G-CSF) are used to mobilize stem cells from the bone marrow into the bloodstream, making it easier to collect them for transplant.